CFO interim
Peraso Inc. names Ronald Glibbery interim CFO
Peraso Inc. reported in a Form 8-K filed September 11, 2026 that Ronald Glibbery was named interim Chief Financial Officer and Secretary, effective October 2, 2026.
In the filing's words
On September 8, 2026, James Sullivan notified Peraso Inc. (the “Company”) of his resignation as Chief Financial Officer and Secretary of the Company and from his positions as an officer and director of the Company’s subsidiaries, effective October 2, 2026 (the “Resignation”).
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Peraso Inc. (PRSO) |
|---|---|
| Event | Interim |
| Incoming | Ronald Glibbery |
| Outgoing | James Sullivan |
| Title in the filing | interim Chief Financial Officer and Secretary |
| Effective | October 2, 2026 |
| 8-K filed | September 11, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Chief Executive Officer and a member of the Board, Peraso Inc. |
| SEC CIK | 0000890394 |
Peraso Inc. reported this change in a Form 8-K, Item 5.02, filed September 11, 2026. The filing's own words are quoted above.
Also filed in September 2026
Other CFO moves on the record that month. All moves.
6 weeks ago· 2026-09-30InterimACI
Albertsons Companies, Inc. names Cody Perdue interim CFO
6 weeks ago· 2026-09-30DepartureALDA
Atlantica Inc. discloses CFO departure: Shelley Goff
6 weeks ago· 2026-09-30TransitionCARL
Carlsmed, Inc. CFO transition: Richard Heppenstall to succeed Leo Greenstein
6 weeks ago· 2026-09-30AppointmentLEVI
Levi Strauss & Co. appoints John Vandemore as CFO
6 weeks ago· 2026-09-30DeparturePTPI
Petros Pharmaceuticals, Inc. discloses CFO departure: Robert Weinstein
6 weeks ago· 2026-09-30DepartureTCRX
TScan Therapeutics, Inc. discloses CFO departure: Jason A. Amello
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Ronald Glibbery? Send a correction with the primary source.